Scientific publications
Marcos Ladreda, ETERNA founder, is co-author of research published in Diagnostics (MDPI, 2021) on blood biomarkers for stroke detection, and is actively involved in cancer biomarker research.
SOBRE NOSOTROS
Biotech specialized in monitoring health
Our products use biological and lifestyle parameters to control the physical state and well-being of the body. We use our own patented technology.
Our Mission
Help to live more and better
By relying on epigenetics, our goal is to reveal in real time the impact that the environment around us has on the organism. We also use this information to improve health, prevent diseases and extend life expectancy.
Promote healthy lifestyle in the youth population
Inspiring young generations to adopt a healthier lifestyle is vital for the overall well-being of the population and for promoting healthy aging. The improvement of physical form, the increase of mental resilience and the protection against developing age-related diseases are some of its benefits. Educating young people about the importance of healthy habits from an early age will equip them with informed decisions and create a healthier future for our society.
In-house research, published results
Behind ETERNA is a team with real experience in biomarker discovery and medical diagnostics.
Regulated diagnostics experience
Co-founder of UpFront Diagnostics (Cambridge, UK), where he developed the biomarker panel for the first rapid blood test for stroke (LVOne), validated across NHS hospitals.
Training and collaborations
Trained at the University of Oviedo in the environment of international leaders in biomedicine and aging. Collaborates with Marcos Vázquez (Fitness Revolucionario) in the design and communication of ETERNA's health approach.
Founder's research and publications
Peer-reviewedDiagnostics · 2021
A Novel Combination of Blood Biomarkers and Clinical Stroke Scales Facilitates Detection of Large Vessel Occlusion Ischemic Strokes
DOI: 10.3390/diagnostics11071137
PreprintPreprints.org · 2026
Two Highly Specific Mouse Monoclonal Antibodies to the Putative C-Telopeptide of Human Collagen XIα1, a Cancer Biomarker
DOI: 10.20944/preprints202601.1738.v1
Not peer‑reviewed (preprint).
Note: A preprint is a public manuscript that has not yet undergone peer review. We include it as part of our commitment to scientific transparency.
Public Grants Conceded
Institutional recognition of our innovation project
Grant for Technology-Based Companies in the Principality of Asturias Phase II
Startquake S.L.’s project to commercialize its Test de edad biológica and ActiveAge products has been subsidized under the Technology-Based Companies Grant Phase II of the Principality of Asturias. The project has been co-financed by the Government of the Principality of Asturias through the SEKUENS Agency and the Science, Technology and Innovation Plan (PCTI) 2018-2022, and by the European Union through ERDF.
Grant for the incorporation of university graduates for the development of R&D activities
The grant supports the hiring of graduates to carry out R&D activities. The project covered by the grant is titled “Testing and validation of ‘in silico’ biomarkers”. It is co-financed by the Government of the Principality of Asturias through the Foundation for the Promotion of Applied Scientific Research and Technology in Asturias (FICYT) and by the European Union through the European Regional Development Fund (ERDF).
Reference: AYUD/2021/57092
Grant for Technology-Based Companies in the Principality of Asturias Phase II
Startquake S.L.’s project to commercialize its Test de edad biológica and ActiveAge products has been subsidized under the Technology-Based Companies Grant Phase II of the Principality of Asturias. The project has been co-financed by the Government of the Principality of Asturias through the SEKUENS Agency and the Science, Technology and Innovation Plan (PCTI) 2018-2022, and by the European Union through ERDF.
Grant for the 'TE CUIDAS' project - Scientific Missions in the Principality of Asturias
Startquake S.L., together with a consortium of companies, has been a beneficiary of this grant under the “TE CUIDAS” programme. The project develops technologies aimed at supporting healthy, autonomous longevity for vulnerable groups at risk of social exclusion. The grant was funded by the Regional Ministry of Science, Innovation and Universities under the Scientific Missions programme of the Principality of Asturias 2022.
Reference: AYUD/2022/24232Period: 07/01/2022 - 09/30/2023Amount: €220,444.08
Grant 'Activa Startups' - Open Innovation Boost
Startquake S.L.’s project “Development of bespoke tests for Startquake analysis” has been subsidized under the “Activa Startups” grant within the Recovery, Transformation and Resilience Plan for SMEs in the Autonomous Community of Asturias (ATS_PYME_007). It is funded by the European Union – Next Generation EU, and by the Ministry of Industry, Commerce and Tourism.
Grant 'Industrial PhDs' - Torres Quevedo Programme
The reference for the grant received by Startquake S.L. is DIN2020-011530; it was funded by the Ministry of Science and Innovation (MCIN) and the State Research Agency (AEI), agency DOI 10.13039/501100011033. This grant falls under support for doctoral training in companies through the “Torres Quevedo” initiative.
Reference: DIN2020-011530
TIC CECOEC innovation promotion programme
Startquake S.L. has been funded through the project “Measuring ageing with wearable technology”, awarded by the Chambers of Commerce of Asturias as part of the Recovery, Transformation and Resilience Plan – financed by the European Union – NextGenerationEU.